RS Investment Management’s Edwards Lifesciences EW Stock Holding History

RS Investment Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	$9.08M	Sell	273,270 -273,255	-50%	-$9.35M	0.09%	241
2016 Q1	$16.1M	Buy	546,525 +41,550	+8%	+$1.15M	0.16%	200
2015 Q4	$13.3M	Sell	504,975 -63,735	-11%	-$1.66M	0.12%	212
2015 Q3	$13.5M	Buy	568,710 +153,000	+37%	+$3.69M	0.12%	213
2015 Q2	$9.87M	Buy	415,710 +57,984	+16%	+$1.31M	0.08%	252
2015 Q1	$8.49M	Sell	357,726 -7,308	-2%	-$164K	0.08%	253
2014 Q4	$7.67M	Sell	365,034 -9,726	-3%	-$195K	0.07%	255
2014 Q3	$6.38M	Buy	+374,760	New	+$5.92M	0.06%	274

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return

RS Investment Management's EW Position: Q2 2016 in Review

RS Investment Management reduced its Edwards Lifesciences (EW) stake by 50% in Q2 2016, selling an estimated $9.35M and leaving 273,270 shares worth $9.08M. The position accounts for 0.09% of the portfolio, ranked #241.

RS Investment Management first reported a position in EW in Q3 2014 and has held it in 8 quarters since. The position peaked at $16.1M in Q1 2016. 693 funds tracked by Wall St. Rank hold EW as of Q2 2016.

RS Investment Management held 273,270 shares of Edwards Lifesciences worth $9.08M as of Q2 2016.
RS Investment Management sold 273,255 Edwards Lifesciences shares in Q2 2016, an estimated $9.35M.
Edwards Lifesciences made up 0.09% of RS Investment Management's portfolio in Q2 2016, its #241 holding.
RS Investment Management first reported a position in Edwards Lifesciences in Q3 2014 and has held it in 8 quarters since.
RS Investment Management's Edwards Lifesciences position peaked at $16.1M in Q1 2016.
693 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2016.

Based on RS Investment Management's 13F filing for Q2 2016, filed 26 Jul 2016.